Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3063% above fair value
$4.09−0.11 (-2.62%)
Close on Nov 12, 2026Market cap $256.66MP/E –Yield 0.00%
Camp4 Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Camp4 Therapeutics's enterprise value was $131.70M on Nov 11, 2026, against $101.27M a year earlier. Over the last 3 years it ranged from -$39.82M to $210.50M, with a median of $14.92M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $131.70M | -37.4% |
| 2025 | Dec 31, 2025 | $210.50M | +19054.2% |
| 2024 | Dec 31, 2024 | $1.10M | – |
See a number that looks wrong?